Application 202513

Type: NDA
Sponsor: ALLERGAN

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	GELNIQUE 3%	OXYBUTYNIN	GEL, METERED;TRANSDERMAL	3%	Yes	No

Documents#

Document, Submission type, Date table
Document	Submission type	Date
19354	SUPPL	2015-07-13
10060	SUPPL	2015-07-13
40189	SUPPL	2013-01-11
32269	SUPPL	2013-01-11
44859	ORIG	2012-06-26
43405	ORIG	2012-06-26
10059	ORIG	2011-12-14
40188	ORIG	2011-12-13